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1 |  INTRODUCTION
Breast tuberculosis is a rare condition, especially as primary 
manifestation.1 The incidence is estimated to be 0.1% of 
breast diseases in developed countries, but it reaches 3%‐4% 
in countries where tuberculosis is endemic.2-4 Mammary tu-
berculosis mostly appears in multiparous, lactating women 
and in association with immunosuppressive disorders, in-
cluding HIV.5,6 The diagnosis can be difficult because the 
disease may mimic breast carcinoma, pyogenic abscess, and 
other granulomatous diseases.7,8
2 |  CASE REPORT
A 31‐year‐old Chinese woman without chronic diseases 
and without familiar history of breast cancer was sent from 
Radiology to the Breast Surgery Department showing pain 
and purulent discharge from the right nipple. The cytologi-
cal test on the material showed neutrophils and macrophages; 
ultrasound showed a centimetric hypoechoic subareolar le-
sion, as for a breast abscess. The patient was treated with 
empirical antibiotic therapy (Amoxicillin and Clavulanic 
Acid 1g every 12 hours for 6 days) with regression of symp-
toms. After three months the nipple discharge reappeared. 
Ultrasound showed only a ductal ectasia. The total leukocyte 
count and other blood tests were normal. The patient under-
went again antibiotic treatment together with surgical right 
ductgalactophorectomy and toilette of the abscess. The his-
tology of the specimen confirmed ductal ectasia, acute and 
chronic inflammation. After surgery a leak of dense material 
persisted. A culture was performed and an Escherichia Coli 
ESBL + grew up. The infectious diseases specialist prescribed 
a specific antibiotic therapy with IV Ertapenem 1 g/day for 
7 days, which led to regression of symptoms. In the following 
two months, the patient was treated for several episodes of 
breast inflammation and purulent nipple leak. She underwent 
antibiotic therapy with Piperacilline  +  Tazobactam (4.5  g 
3× per day for 7 days) and then ertapenem again with the 
same posology, and surgical toilette of the region was re-
peated twice. Nevertheless, the purulent secretion persisted, 
so we considered breast tuberculosis in differential diagno-
sis. QuantiFERON‐TB Gold assay was positive (presence 
of cell‐mediated immune response to antigens ESAT‐6 and 
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Mammary tuberculosis is exceptional in developed countries. It can mimic an ab-
scess or a granulomatous mastitis. In subjects coming from endemic areas, it is nec-
essary to suspect a tuberculosis infection in case of recurrent mastitis refractory to 
antibiotics. Positivity of Quantiferon‐TB Gold assay can help to confirm the clinical 
suspicion.
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CFP‐10 of Mycobacterium tuberculosis), but it was not pos-
sible to identify the Mycobacterium tuberculosis in the speci-
mens of the wound. A chest X‐ray was negative, but because 
of the clinical nonresponse to antibiotic and of the results of 
QuantiFERON‐TB, a diagnosis of primary breast tubercu-
losis was made. The patient was treated with antitubercular 
drugs (rifampicin, isoniazid, pyrazinamide, and ethambutol) 
for three months, and she continued rifampicin and isoniazid 
for three additional months. In the follow‐up period of one 
year, there was no evidence of persistent disease.
3 |  DISCUSSION
BT is an extremely rare disease, first described in 1829.9 It 
can be primary (tuberculosis affects only the breast) and sec-
ondary (tuberculosis affects other organs).10 According to the 
latest classification, BT can present as nodular, disseminated, 
and tubercular abscess. The nodular type presents as a well‐
defined mass that progressively involves the skin, sometimes 
causing ulceration. It is more frequent in the elderly. The dis-
seminated type presents as multiple foci that can lead to con-
fluence. The tubercular abscess is characterized by a cavity 
similar to other bacterial abscess, but that can later caseate.5 
Our patient had a tubercular abscess.
In the diagnosis, mammography has low sensitivity. 
Ultrasound can show a hypoechoic mass in 60% of patients, 
focal or sectorial duct ectasia in 40%.11 The gold standard 
for the diagnosis is detection of M  tuberculosis by Ziehl‐
Neelsen staining or by culture. Fine needle aspiration cy-
tology (FNAC) is generally performed to detect the bacilli 
by the stains or the presence of epithelioid cells and granu-
lomas.12 In our report, a FNAC was performed but was not 
diagnostic. FNAC is typically inconclusive, and the acid‐fast 
bacilli are usually not seen even in culture.13 Histopathology 
of the lesion can be useful to identify chronic granuloma-
tous inflammation with caseous necrosis.14 In our case, the 
clinical diagnosis was only supported by the positivity of 
QuantiFERON‐TB Gold assay.
It is important to consider BT in differential diagnosis 
with breast carcinoma, breast abscess that do not regress 
with classical nontubercular antibiotic therapy and other 
granulomatous mastitis,15 especially in patients coming from 
countries where the infection is endemic and in patients with 
immunodeficiency. A multidrug‐resistant infection should be 
excluded.
Since the disease could represent a diagnostic challenge, 
the research of M Tuberculosis either by histology or by cul-
ture is mandatory in patients at risk.
The treatment of breast tuberculosis is medical with anti-
tubercular drugs.16 The surgical drainage and resection of the 
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